We are live on ! Find out more
QCG

Quadrant Capital Group Portfolio holdings

AUM $3.34B
1-Year Est. Return 29.16%
This Fund
S&P 500
This Quarter Est. Return
-0.75%
1 Year Est. Return
+29.16%
3 Year Est. Return
+77.72%
5 Year Est. Return
+92.59%
10 Year Est. Return
+303.92%
AUM
$276M
AUM Growth
+$24.9M
Cap. Flow
+$30.6M
Cap. Flow %
11.11%
Top 10 Hldgs %
20.76%
Holding
2,326
New
130
Increased
835
Reduced
304
Closed
60

Top Buys

Rank Stock Value
1
TGT icon
Target
TGT
+$9.21M
2
EFA icon
iShares MSCI EAFE ETF
EFA
+$1.76M
3
KMB icon
Kimberly-Clark
KMB
+$1.7M
4
VNQ icon
Vanguard Real Estate ETF
VNQ
+$1.5M
5
AAPL icon
Apple
AAPL
+$1.26M

Sector Composition

Rank Sector Weight
1 Financials 11.06%
2 Technology 10.02%
3 Consumer Staples 9.8%
4 Healthcare 7.77%
5 Industrials 6.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PENN icon
1101
PENN Entertainment
PENN
$2.74B
$8K ﹤0.01%
316
POST icon
1102
Post Holdings
POST
$4.12B
$8K ﹤0.01%
183
+113
+161% +$5.71K
QLYS icon
1103
Qualys
QLYS
$4.84B
$8K ﹤0.01%
148
+117
+377% +$8.07K
RDY icon
1104
Dr. Reddy's Laboratories
RDY
$9.82B
$8K ﹤0.01%
1,530
+240
+19% +$1.68K
RGLD icon
1105
Royal Gold
RGLD
$17.1B
$8K ﹤0.01%
123
SCI icon
1106
Service Corp International
SCI
$11.4B
$8K ﹤0.01%
269
TRN icon
1107
Trinity Industries
TRN
$2.97B
$8K ﹤0.01%
453
TSCO icon
1108
Tractor Supply
TSCO
$16.3B
$8K ﹤0.01%
765
-20
-3% -$279
ULH icon
1109
Universal Logistics Holdings
ULH
$416M
$8K ﹤0.01%
403
WST icon
1110
West Pharmaceutical
WST
$23.1B
$8K ﹤0.01%
102
ZBRA icon
1111
Zebra Technologies
ZBRA
$12.4B
$8K ﹤0.01%
76
NVRO
1112
DELISTED
NEVRO CORP.
NVRO
$8K ﹤0.01%
+95
New +$7.67K
CNSL
1113
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
$8K ﹤0.01%
787
+78
+11% +$936
AGR
1114
DELISTED
Avangrid, Inc.
AGR
$8K ﹤0.01%
179
SIX
1115
DELISTED
Six Flags Entertainment Corp.
SIX
$8K ﹤0.01%
158
SGEN
1116
DELISTED
Seagen Inc. Common Stock
SGEN
$8K ﹤0.01%
162
VMW
1117
DELISTED
VMware, Inc
VMW
$8K ﹤0.01%
78
SJI
1118
DELISTED
South Jersey Industries, Inc.
SJI
$8K ﹤0.01%
473
+315
+199% +$8.85K
PTR
1119
DELISTED
PETROCHINA COMPANY LIMITED ADS (REP 100 H SHARES)
PTR
$8K ﹤0.01%
119
NTUS
1120
DELISTED
Natus Medical Inc
NTUS
$8K ﹤0.01%
272
+247
+988% +$7.82K
SC
1121
DELISTED
SANTANDER CONSUMER USA HOLDINGS INC
SC
$8K ﹤0.01%
540
CATM
1122
DELISTED
Cardtronics plc Class A Ordinary Shares (UK)
CATM
$8K ﹤0.01%
469
+50
+12% +$1.19K
GNMK
1123
DELISTED
GenMark Diagnostics, Inc
GNMK
$8K ﹤0.01%
+1,500
New +$7.46K
AMTD
1124
DELISTED
TD Ameritrade Holding Corp
AMTD
$8K ﹤0.01%
174
DPLO
1125
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
$8K ﹤0.01%
590
+172
+41% +$4.01K

Similar funds

Quadrant Capital Group's Q1 2018 Portfolio in Review

As of Q1 2018, Quadrant Capital Group held 2,326 positions worth $276M, up 9.9% from $251M the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Quadrant Capital Group deployed $30.6M of net new capital in Q1 2018, opening 130 new positions and adding to 835 existing holdings. Its largest new stake was Schwab Fundamental US Large Company Index ETF: 34,440 shares worth $417K.

By sector, the portfolio is most concentrated in Financials at 11% of assets, down from 12% a quarter earlier, followed by Technology and Consumer Staples.

On the sell side, the largest reduction was Meridian Bioscience Inc, an estimated $2.34M trimmed.

  • Quadrant Capital Group's largest Q1 2018 buy was Schwab Fundamental US Large Company Index ETF: 34,440 shares worth $417K.
  • Quadrant Capital Group added most to Target in Q1 2018, an estimated $9.21M increase.
  • Quadrant Capital Group's biggest Q1 2018 reduction was Meridian Bioscience Inc, cutting an estimated $2.34M.
  • Quadrant Capital Group fully exited CNH Industrial in Q1 2018, selling an estimated $130K.
  • Quadrant Capital Group's ten largest holdings make up 21% of its $276M portfolio in Q1 2018.
  • Quadrant Capital Group opened 130 new positions and closed 60 in Q1 2018.
  • Quadrant Capital Group's portfolio value rose 9.9% quarter-over-quarter to $276M.

Based on Quadrant Capital Group's 13F filing for Q1 2018, filed 10 May 2018.